David has been a Consultant Dermatologist at Salford for 25 years.

He has a general dermatology practice and has run a specialist HS clinic, with dermatology, plastic surgery and specialist nursing colleagues for the past five years.

Presentation at The Society of Tissue Viability 2022 Conference

Hidradenitis suppurativa – an overview

Objectives

After attending this session, persons will be able to:

• Recognise symptoms and signs of HS
• Understand the impact of HS on patients
• Understand available treatment options

Abstract

Hidradenitis suppurativa is a relatively common disease which can have a devastating impact on the quality of life of more severely affected patients. It has historically been under-recognised so that many patients wait many years for a diagnosis and, even when diagnosed, treatment options have been limited. Recent advances in therapy have improved the outlook for many patients but for others HS remains a very difficult condition to live with for many patients and long term multidisciplinary support may be needed.